Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorNantes University Hospital
About this trial
This is a multicenter genetic study aimed at identifying new genes/variants associated with sudden infant death syndrome (SIDS) based on whole-genome sequencing of family trios
Eligibility criteria
Qualifiers
Child included in the French SUDI registry with effective participation in the biocollection
Children who also meet the inclusion criteria for the BIOMINRISK-NEUROBIO (axis 2) and BIOMINRISK-RADIO-ANAT (axis 3) studies in the overall BIOMINRISK project.
Biological parents of the child included in the BIOMINRISK study
Parents who have both signed the consent form for blood collection and inclusion of their samples in the biocollection
Disqualifiers
Presence of a known metabolic, genetic or syndromic pathology at the time of death
Parent under guardianship
Presence of a known metabolic, genetic or syndromic pathology
Trial design
Treatments tested in this trial
- whole genome sequencing
Treatment groups
650 Participants
are divided into 2 treatment groupsSponsors and collaborators
Nantes University Hospital
Lead sponsor
AXA Assurances VIE Mutuelle
Collaborator
Institut du Thorax
Collaborator
Source ClinicalTrials.gov